Trial Profile
Comparative effects of Nebivolol and Carvedilol on orthostatic hypotension in hypertensive patients with type 2 diabetes mellitus (DIANECA).
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Sep 2014
Price :
$35
*
At a glance
- Drugs Carvedilol (Primary) ; Nebivolol (Primary)
- Indications Hypertension
- Focus Adverse reactions
- Acronyms DIANECA
- Sponsors Menarini
- 21 Jul 2012 Actual end date (8 Oct 2009) added as reported by European Clinical Trials Database record.
- 21 Jul 2012 HEXAL added as associations as reported in the European Clinical Trials Database record.
- 21 Jul 2012 Status changed from recruiting to completed as reported by European Clinical Trials Database.